Press release content from Globe Newswire. The AP news staff was not involved in its creation.
TOMI SteraMist Disinfection Provides Highest Clean for Merakey
TOMI Environmental Solutions, Inc.December 23, 2020 GMT
BEVERLY HILLS, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP), is pleased to showcase a highly-valued customer relationship with Merakey Behavioral Health.
Merakey provides education, support and therapy services in the areas of intellectual and developmental disability, behavioral health, autism, and addiction recovery to children and adults. It has locations in 12 states with a heavy concentration throughout Pennsylvania, placing great confidence in the SteraMist te
To embed, copy and paste the code into your website or blog:
COVID-19 vaccines are finally here. The rollout has begun in healthcare settings across the nation. However, despite broad support for the vaccines and their near-universal endorsement by the medical community, many individuals have concerns about being vaccinated for a variety of personal, medical or religious reasons. If employers mandate vaccination, there may be significant numbers of workers across the country who will object. What is an employer to do?
On December 16, 2020, the Equal Employment Opportunity Commission (EEOC) issued much-anticipated updated
See Section K.), which provides guidance specific to COVID-19 mandatory vaccination programs. The good news for employers? The updated guidance is consistent with the EEOC’s past advice, as well as the guidance of other regulatory agencies, including the Centers for Disease Control and Prevention (CDC), and countless health care advocacy groups and professional
FREDERICK, Md., Dec. 17, 2020 (GLOBE NEWSWIRE) TOMI Environmental Solutions, Inc.
® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized
Hydrogen Peroxide (iHP), today announced that it has received a follow-on order from ITH Pharma Limited (ITH), for the integration of a second SteraMist Custom Engineered System (CES) into their facility.
ITH is an industry leader in aseptic compounding services, mixing drugs into ready-to-use IV preparation, applicable to every area of therapy and strives to set new standards in supplying specialized, manufactured products to medical professionals and their patients. The company must comply with stringent decontamination levels as required by regulatory agencies such as the Medicines and Healthcare products Regulatory Agency (MHRA), and with th
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
TOMI Continues the Deployment of SteraBot™ Disinfection Robot at Multiple Healthcare and .
TOMI Environmental Solutions, Inc.December 15, 2020 GMT
FREDERICK, Md., Dec. 15, 2020 (GLOBE NEWSWIRE) TOMI Environmental Solutions, Inc.® (“TOMI”, “the Company”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology Platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP™), announces the continued deployment of SteraBot™, a pilot disinfection robot, at healthcare, research and educational facilities. SteraBot is a first generation robot Tomi has jointly developed with RV Automation Technology Co. Ltd. to ensure the delivery of superior disinfection. SteraBot has now been successfully deployed in five locations: in Hong Kong at the
David Calfee to be sixth Editor of Infection Control & Hospital Epidemiology
ARLINGTON, Va. (December 15, 2020) The Society for Healthcare Epidemiology of America (SHEA) has named David P. Calfee, MD, MS, professor of medicine in the Division of Infectious Diseases and professor of population health sciences at Weill Cornell Medicine, the sixth editor-in-chief of
Infection Control & Hospital Epidemiology. Dr. Calfee will begin his transition into the role in July 2021. Dr. Calfee was chosen from a competitive field of applicants because of his strong vision for the journal and his commitment to publishing the best research in healthcare epidemiology, infection prevention, and antibiotic stewardship, said David Henderson, MD, president of SHEA. Dave outlined clear objectives for building on the journal s strengths, collaborating with SHEA staff, and engaging with authors.